| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
61 |
| Employees |
161 |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-616 |
| Cash Flow (TTM) (Millions $) |
5 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Arena Pharmaceuticals Inc is a biopharmaceutical company headquartered in San Diego, California. It was founded in 1997 by Jack Lief and Dominic Behan. Arena Pharmaceuticals focuses on discovering, developing, and commercializing innovative medicines that address unmet medical needs. It uses its proprietary drug discovery platform, which includes computational chemistry, receptor pharmacology, pharmacokinetics, and medicinal chemistry.
The company's leading drug candidate is etrasimod, which is being developed for the treatment of multiple conditions, including ulcerative colitis, Crohn's disease, atopic dermatitis, and alopecia areata. Etrasimod is a highly selective, oral S1P receptor modulator that works by reducing the number of white blood cells that cause inflammation. The drug has shown promising results in clinical trials, with the potential to be a significant breakthrough in the treatment of these diseases.
In addition to etrasimod, Arena Pharmaceuticals has a diverse pipeline of drug candidates that are being developed for the treatment of other diseases, including pulmonary arterial hypertension, cystic fibrosis, and hypertension. The company has partnerships with various pharmaceutical companies, including United Therapeutics, Boehringer Ingelheim, and Everest Medicines, to collaborate on the development and commercialization of its drugs.
Arena Pharmaceuticals has a strong financial position, with a market capitalization of over $1 billion and a cash and cash equivalents balance of over $960 million as of 202 The company's revenue is primarily generated from collaborative research and development agreements and license agreements, as well as milestone payments and royalties from its partners.
The company is committed to conducting its business operations in a socially and environmentally responsible manner. It conducts ethical research practices and adheres to the highest standards of corporate governance, transparency, and compliance with legal and regulatory requirements.
In conclusion, Arena Pharmaceuticals is a leading biopharmaceutical company that is focused on developing innovative drugs for the treatment of various diseases. With a strong pipeline of drug candidates and strategic partnerships, the company is well-positioned for growth and success in the future.
Company Address: 136 Heber Avenue Park City 84060 UT
Company Phone Number: 453.7200 Stock Exchange / Ticker: NASDAQ ARNA
|
%
5.06% 